MedTrace Logo

Use of Alternative Medicine in Patients With Dementia and Mild Cognitive Dysfunction

NCT01554475 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 151

Last updated 2015-02-18

No results posted yet for this study

Summary

So far, no drugs have shown to stop or delay the pathological processes of dementia. Available pharmacological treatment includes a small number of drugs; cholinesterase inhibitors like donepezil, galantamine and rivastigmine, and the NMDA receptor antagonist memantine, all of which only affect the symptoms of the disease. At the same time, alternative medicines like herbal products and dietary supplements are often intensively marketed with the assertion of curative or alleviating effects on dementia. The documentation of clinical effects, side effects and the potential for interaction with prescribed drugs are, however, generally scarce. The aims of this study are to make a survey of the use of alternative medicine in patients with dementia and mild cognitive dysfunction attending the investigators out-patient dementia clinic, and to assess the interaction potential with the patient's other medications.

Conditions

Sponsors & Collaborators

  • Kløveråsen Center for dementia, Bodø

    collaborator UNKNOWN

  • University Hospital of North Norway

    lead OTHER

Principal Investigators

  • Trude Giverhaug, PhD · University Hospital North-Norway

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2014-10-31
Completion
2014-10-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01554475 on ClinicalTrials.gov